Viral RNA Polymerase Inhibitors
Infections by RNA viruses continue to exist as significant public health problems worldwide. In response to the urgent need for safer and more efficacious treatment options against infections caused by RNA viruses, the pharmaceutical and biotechnology industries have devoted significant efforts over the last two decades to discovering and developing new antiviral agents. As the primary viral enzyme responsible for genome replication and transcription, RNA-dependent RNA polymerases (RdRps) emerged early and remained as one of the most promising targets for therapeutic intervention of RNA virus infections. Advances in both basic research and drug discovery technology have resulted in the identification of a significant number of nucleoside (NIs) and non-nucleoside inhibitors (NNIs) of viral RdRps. In this chapter, we will focus our attention on various classes of viral RdRp inhibitors, with main emphases on those of hepatitis C virus (HCV) due to its significant unmet medical need. Recent progress in understanding their mechanism of action, antiviral activity profiles, and emergence of drug resistance mutations will be discussed.
- Afdhal, N. (2004). Annual Meeting of the American Association for the Study of Liver Diseases. Boston.Google Scholar
- Olsen, D., M. Davies, et al. (2006). The Nucleoside Inhibitor MK-0608 Mediates Suppression of HCV Replication for >30 Days in Chronically Infected Chimpanzees 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco.Google Scholar
- Olsen, D. B. (2006). Hepatitis C virus resistance to new antivirals 15th International HIV Drug Resistance Workshop. Sitges, Spain.Google Scholar
- Roberts, S., G. Cooksley, et al. (2006). Results of a Phase 1B, Multiple Dose Study of R1626, a Novel Nucleoside Analog Targeting HCV Polymerase in Chronic HCV Genotype 1 Patients. 57th Annual Meeting of the American Association Boston, MA.Google Scholar
- Shih, I., A. Huang, et al. (2007). 14th International Symposium On Hepatitis C Virus and Related Viruses, Glasgow, UK.Google Scholar